Skip to main content
Log in

Diltiazem and verapamil: Functional antagonism of exogenous noradrenalin and angiotensin II in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

To evaluate the possible functional antagonism of the calcium antagonists diltiazem and verapamil of the sympathetic nervous system and the renin-angiotensin system, their influence on blood pressure, heart rate, plasma catecholamines and renin activity (PRA), and on the reaction of these parameters to exogenous noradrenaline (NA) and angiotensin II, was investigated in 8 normotensive volunteers. Intravenous diltiazem or verapamil caused a sharp, shortlasting decrease in systolic and diastolic blood pressure, with a maximum 1–3 min after injection and a duration of 10–15 min. Even a further infusion of the calcium antagonists was unable to maintain the initial hypotensive effect. The cessation of the hypotensive effect was not due to reflex stimulation of the sympathetic nervous system, as indicated by unchanged plasma NA and adrenaline levels in the case of diltiazem, but was associated with an increase in PRA. During the administration of diltiazem and verapamil, the increase in blood pressure in response to the infusion of NA and angiotensin II was attenuated; the increase in diastolic pressure was mainly affected. The inhibition was more pronounced at the higher infusion rate of NA and angiotensin II. On the basis of these findings it is suggest that the hypotensive activity of calcium antagonists can be at least partly attributed to a reduction in vascular tone which is maintained by the postjunctional action of noradrenaline and angiotensin II.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bender F (1970) Die Behandlung der tachykarden Arrhythmien und der arteriellen Hypertonie mit Verapamil. Arzneimittelforsch (Drug Res) 29: 1310–1316

    Google Scholar 

  2. Brittinger WD, Schwarzbeck A, Wittenmeier KW, Twittenhoff WD, Stegaru B, Huber H, Ewald RW, von Henning GE, Fabricius M, Strauch M (1970) Klinisch-experimentelle Untersuchungen über die blutdrucksenkende Wirkung von Verapamil. Dtsch Med Wochenschr 95: 1871–1877

    Google Scholar 

  3. Cavero I, Lefèvre-Borg F (1981) Effects of diltiazem and verapamil on pressor responses mediated by stimulation of alpha1-, alpha2-adrenoceptors, angiotensin II and 5-hydroxy-tryptamine receptors in pithed rats. Br J Pharmacol 74: 839

    Google Scholar 

  4. Corea L, Miele N, Bentivoglio M, Boschetti E, Agabiti-Rosei E, Muiesan C (1979) Acute and chronic effects of nifedipine on plasma renin activity and plasma adrenaline and noradrenaline in controls and hypertensive patients. Clin Sci 57: 115s-117s

    Google Scholar 

  5. DaPrada M, Zürcher G (1976) Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomol range. Life Sci 19: 1161–1174

    Google Scholar 

  6. Elliott HL, Reid JL (1983) Evidence for postjunctional vascular alpha2-adrenoceptors in peripheral vascular regulation in man. Clin Sci 65: 237–241

    Google Scholar 

  7. Guazzi M, Olivari MT, Polese A, Fiorentini C, Magrini F, Moruzzi P (1977) Nifedipine, a new antihypertensive with rapid action. Clin Pharmacol Ther 22: 528–532

    Google Scholar 

  8. Hörtnagl H, Magometschnigg D, Prager J (1982) Hyperkinetic heart syndrome: the role of the sympathetic nervous system. Cardiology 69: 74–83

    Google Scholar 

  9. Langer SZ, Shepperson NB (1982) Recent developments in vascular smooth muscle pharmacology: the postsynaptic alpha2-adrenoceptor. Trends Pharmacol Sci 3: 440–444

    Google Scholar 

  10. Lederballe Pedersen O (1981) Calcium blockers as a therapeutic principle in arterial hypertension. Acta Pharmacol Toxicol 49 [Suppl 2]: 1–31

    Google Scholar 

  11. Lederballe Pedersen O, Christensen NJ, Rämsch KD (1980) Comparison of acute effects of nifedipine in normotensive and hypertensive man. J Cardiovasc Pharmacol 2: 357–366

    Google Scholar 

  12. Lewis GRJ (1982) The long-term management of hypertension with verapamil. Clin Exp Pharmacol Physiol [Suppl 6]: 107–112

    Google Scholar 

  13. McGrath JC (1982) Evidence for more than one type of postjunctional alpha-adrenoceptor. Biochem Pharmacol 31: 467–484

    Google Scholar 

  14. Mendelsohn FAO, Doyle AE, Gray GW (1980) Lack of response of sympathetic nervous system to angiotensin infusion. Lancet 1: 492–493

    Google Scholar 

  15. Millar JA, McLean K, Reid JL (1981) Calcium antagonists decrease adrenal and vascular responsiveness to angiotensin II in normal man. Clin Sci 61: 65s-68s

    Google Scholar 

  16. Nicholls MG, Espiner EA, Miles KD, Zweifler AJ, Julius S (1981) Evidence against an interaction of angiotensin II with the sympathetic nervous system in man. Clin Endocrinol 15: 423–430

    Google Scholar 

  17. Peuler JD, Johnson GA (1977) Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21: 625–636

    Google Scholar 

  18. Rowe BP, Nasjletti A (1981) The effect of angiotensin II infusion on plasma catecholamines in the conscious rabbit. Proc Soc Exp Biol Med 168: 110–113

    Google Scholar 

  19. Singh BN, Ellrodt G, Peter CT (1978) Verapamil: a review of its pharmacological properties and therapeutic use. Drugs 15: 169–197

    Google Scholar 

  20. Starke K, Docherty JR (1981) alpha1- and alpha2-adrenoceptors: Pharmacology and clinical implications. J Cardiovasc Pharmacol 3 [Suppl 1]: s14–23

    Google Scholar 

  21. Timmermans PBMWM, VanZwieten PA (1981) The postsynaptic alpha2-adrenoceptor. J Auton Pharmac 1: 171–183

    Google Scholar 

  22. Van Brummelen P, Vermey P, Timmermans PBMWM, Van Zwieten PA (1982) Preliminary evidence for a postsynaptic alpha2-adrenoceptor in the vasculature of the human forearm. Br J Clin Pharmacol 15: 134P

  23. Van Meel JCA, DeJonge A, Kalkman HO, Wilfert B, Timmermans PBMWM, Van Zwieten PA (1981) Vascular smooth muscle contraction initiated by postsynaptic alpha2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol 69: 205–208

    Google Scholar 

  24. Van Meel JCA, De Zoeten K, Timmermans PBMWM, Van Zwieten PA (1982) Impairment by nifedipine of vasopressor responses to stimulation of postsynaptic alpha2-adrenoceptors in ganglionblocked rabbits. Further evidence for the selective inhibition of postsynaptic alpha2-adrenoceptor-induced pressor responses by calcium antagonists. J Auton Pharmacol 2: 13–20

    Google Scholar 

  25. Van Meel JCA, Timmermans PBMWM, Van Zwieten PA (1983) Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha2-adrenoceptor-mediated vasopressor responses. Eur J Pharmacol 92: 27–34

    Google Scholar 

  26. Vierhapper H, Waldhäusl W (1982) Reduced pressor effect of angiotensin II and noradrenaline in normal man following the oral administration of the calcium antagonists nifedipine. Eur J Clin Invest 12: 263–267

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Magometschnigg, D., Hörtnagl, H. & Rameis, H. Diltiazem and verapamil: Functional antagonism of exogenous noradrenalin and angiotensin II in man. Eur J Clin Pharmacol 26, 303–307 (1984). https://doi.org/10.1007/BF00548759

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00548759

Key words

Navigation